Treatment of Non-Infectious Diarrhea
The cornerstone of treating non-infectious diarrhea is adequate fluid and electrolyte replacement, with oral rehydration solution (ORS) as first-line therapy for mild to moderate dehydration, followed by symptomatic management with antimotility agents in appropriate patients and addressing the underlying cause. 1
Immediate Management: Rehydration
Oral Rehydration Therapy
- Reduced osmolarity ORS is the first-line treatment for mild to moderate dehydration in all age groups with non-infectious diarrhea. 1
- Continue ORS until clinical dehydration is corrected, then switch to maintenance fluids to replace ongoing losses. 1
- Nasogastric administration of ORS may be used in patients with moderate dehydration who cannot tolerate oral intake or are too weak to drink adequately. 1
Intravenous Rehydration
- Use isotonic IV fluids (lactated Ringer's or normal saline) for severe dehydration, shock, altered mental status, or ileus. 1
- Continue IV rehydration until pulse, perfusion, and mental status normalize, then transition to ORS for remaining deficit replacement. 1
Nutritional Support
- Resume age-appropriate usual diet immediately after rehydration is completed. 1
- Continue breastfeeding throughout the diarrheal episode in infants. 1
- Monitor for signs of malnutrition or catabolic state and supplement enteral or parenteral electrolytes, carbohydrates, lipids, amino acids, and vitamins as indicated. 1
Symptomatic Treatment
Antimotility Agents
- Loperamide may be given to immunocompetent adults with non-infectious watery diarrhea once adequately hydrated. 1
- Loperamide is contraindicated in children <18 years of age with acute diarrhea. 1
- Avoid loperamide in inflammatory diarrhea, diarrhea with fever, or when toxic megacolon is a concern. 1
- FDA-approved loperamide is indicated for chronic diarrhea in adults associated with inflammatory bowel disease and for reducing ileostomy discharge volume. 2
Critical Pitfall: Never exceed recommended loperamide doses due to risk of cardiac arrhythmias, QT prolongation, and sudden death. 2
Antiemetic Agents
- Ondansetron may be given to children >4 years of age and adolescents with vomiting to facilitate oral rehydration tolerance. 1
- Antiemetics are not a substitute for fluid and electrolyte therapy but can be considered once the patient is adequately hydrated. 1
Probiotics
- Probiotic preparations may be offered to reduce symptom severity and duration in immunocompetent adults and children with non-infectious diarrhea. 1
Specific Etiologies of Non-Infectious Diarrhea
Paraneoplastic Diarrhea
- Consider VIP-secreting tumors (causing watery diarrhea, hypokalemia, hypochlorhydria), carcinoid tumors (serotonin-producing), or other hormone-secreting tumors (glucagonoma, gastrinoma, somatostatinoma). 1
- Treatment targets the underlying malignancy and hormone excess.
Inflammatory Bowel Disease (IBD)
- Consider IBD as an underlying etiology in patients with symptoms lasting ≥14 days without identified infectious source. 1
- Specific IBD therapy should be initiated based on disease severity and extent.
Irritable Bowel Syndrome (IBS)
- Consider IBS in patients with persistent symptoms ≥14 days without identified cause. 1
- For IBS with diarrhea (IBS-D), options include low-FODMAP diet, 5-HT3 receptor antagonists (alosetron), rifaximin, or low-dose tricyclic antidepressants. 3
- Alosetron is FDA-approved for severe diarrhea-predominant IBS in women, providing relief of pain, urgency, and bowel frequency. 4
Drug-Induced and Other Causes
- Cholestyramine may be used for bile acid diarrhea. 3
- Lactose intolerance should be considered in non-responders to initial therapy. 1
Reassessment for Persistent Symptoms
- Perform clinical and laboratory reevaluation in patients not responding to initial therapy, including consideration of non-infectious conditions like lactose intolerance. 1
- Reassess fluid and electrolyte balance, nutritional status, and treatment approach in patients with persistent symptoms. 1
- Repeat testing for the same pathogen should be avoided to prevent false-positive results. 1
Key Clinical Pitfalls
- Never withhold fluid replacement while pursuing symptomatic treatment—rehydration is always the priority. 1
- Avoid loperamide in children, inflammatory conditions, or when exceeding recommended doses. 1, 2
- Do not assume infectious etiology without workup in chronic diarrhea (≥14 days)—non-infectious causes predominate. 1
- Monitor cancer patients closely for paraneoplastic syndromes and maintain nutritional support. 1